<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-IVM-1975</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-1975</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Поддержание CD4+ центральных и эффекторных клеток памяти в норме и в модели воспаления in vitro</article-title><trans-title-group xml:lang="en"><trans-title>In vitro maintaining of CD4+ central and effector memory cells in normal and inflammatory conditions</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3327-3630</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Блинова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Blinova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Блинова Елена Андреевна – кандидат биологических наук, старший научный сотрудник лаборатории клинической иммунопатологии</p><p>630099, г. Новосибирск, ул. Ядринцевская, 14</p></bio><bio xml:lang="en"><p>Blinova Elena A. , PhD (Biology), Senior Research Associate, Laboratory of Clinical Immunopathology</p><p>630099, Novosibirsk, Yadrintsevskaya str., 14.</p></bio><email xlink:type="simple">blinovaelena-85@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колерова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolerova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колерова Анастасия Викторовна – аспирант лаборатории клинической иммунопатологии</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Kolerova Anstasiia V., Postgraduate Student, Laboratory of Clinical Immunopathology</p><p>Novosibirsk</p></bio><email xlink:type="simple">periosteum@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балясников</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Balyasnikov</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Балясников Владимир Евгеньевич – студент лечебного факультета</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Balyasnikov Vladimir E., Student</p><p>Novosibirsk</p></bio><email xlink:type="simple">vladimirtatarsk@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козлов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Козлов Владимир Александрович – доктор медицинских наук, профессор, академик РАН, заведующий лабораторией клинической иммунопатологии, научный консультант</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Kozlov Vladimir A., PhD, MD (Medicine), Professor, Full Member, Russian Academy of Sciences, Head, Laboratory of Clinical Immunopathology, Scientific Advisor</p><p>Novosibirsk</p></bio><email xlink:type="simple">vakoz40@yndex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБНУ «Научно-исследовательский институт клинической и фундаментальной иммунологии»<country>Россия</country></aff><aff xml:lang="en">Research Institute of Fundamental and Clinical Immunology<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБОУ ВО «Новосибирский государственный медицинский университет»<country>Россия</country></aff><aff xml:lang="en">Novosibirsk State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>27</day><month>11</month><year>2020</year></pub-date><volume>22</volume><issue>5</issue><fpage>837</fpage><lpage>846</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Блинова Е.А., Колерова А.В., Балясников В.Е., Козлов В.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Блинова Е.А., Колерова А.В., Балясников В.Е., Козлов В.А.</copyright-holder><copyright-holder xml:lang="en">Blinova E.A., Kolerova A.V., Balyasnikov V.E., Kozlov V.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/1975">https://www.mimmun.ru/mimmun/article/view/1975</self-uri><abstract><p>В организме ключевым фактором для выживания и поддержания CD4+ центральных (Tcm) и эффекторных (Tem) клеток памяти является IL-7. При многих аутоиммунных заболеваниях детектируется повышенный уровень IL-7 в сыворотке крови, очаге воспаления, что ставит вопрос об участии данного гомеостатического фактора в выживании Т-клеток памяти, в том числе аутореактивных, в условиях воспаления. Целью исследования явилось изучение механизмов поддержания CD4+Т-клеток памяти в норме и в условиях воспаления. Мы разработали модель воспаления in vitro, основанную на индукции провоспалительных цитокинов, и оценили влияние IL-7 на сортированные популяции CD4+Tcm и Tem в норме и в модели воспаления in vitro. IL-7 способствовал сохранению CD4+Tcm во всех вариантах культур. В отсутствие контакта с прилипающей фракцией пролиферативный ответ Tcm и Tem на IL-7 был немного снижен как в норме, так и в условиях воспаления. Что говорит о меньшей чувствительности Т-клеток памяти к контактам с MHC и, возможно, необходимости в дополнительных сигналах для полноценной стимуляции IL-7. В пользу данного утверждения свидетельствуют и данные об экспрессии CD127 и CD132: в отсутствии контакта с MHC доля CD127+CD132+ клеток уменьшалась в обеих субпопуляциях CD4+ клеток памяти. В культурах in vitro IL-7 способствовал снижению экспрессии CD127 и увеличению экспрессии CD132 на CD4+Tcm и Tem. Мы охарактеризовали CD4+Tcm и Tem по аффинности Т-клетокчного рецептора (ТКР), используя уровень экспрессии CD5. Известно, что клетки с высокой аффинностью ТКР к собственным антигенам обладают более высокой экспрессией CD5. Tcm содержали большее количество CD5high клеток по сравнению с Tem. В культурах IL-7 способствовал поддержанию высокого уровня экспрессии CD5 на Tcm, который был сопоставим с уровнем экспрессии в периферической крови. Высокая экспрессия CD5 на Tem наблюдалась при добавлении IL-7 в модели воспаления in vitro. В отсутствие контакта с MHC число CD5high среди CD4+Tem и Tcm снижалось. Таким образом, CD4+Tcm клетки с высоким родством к аутологичным антигенам, возможно, зависимы от наличия гомеостатических факторов, в частности IL-7, и контакта с антигенпрезентирующими клетками (АПК). В условиях воспаления не было выявлено изменений в механизме поддержания CD4+Tcm, в отличие от CD4+Tem. Менее зависимые от IL-7 в обычных условиях, CD4+CD5highTem клетки накапливались в условиях воспаления в присутствии IL-7.</p></abstract><trans-abstract xml:lang="en"><p>IL-7 is a key factor for the survival and maintenance of CD4+ central (Tcm) and effector (Tem) memory cells in the whole body. In many autoimmune diseases, an elevated level of IL-7 is detected in blood serum and at the site of inflammation, thus suggesting participation of this homeostatic factor in the survival of memory T cells, including auto-reactive clones, in inflammatory disorders. The aim of the study was to investigate the mechanisms of maintaining CD4+ memory T cells under normal and inflammatory conditions. We developed an in vitro model of inflammation, based on induction of pro-inflammatory cytokines, and then evaluated the effects of IL-7 upon purified sorted populations of CD4+Tcm and Tem under normal conditions and in vitro inflammatory model. IL-7 treatment promoted maintenance of CD4+Tcm phenotype in all variants of cultures. In the absence of contact with adherent cell fraction, the IL-7-induced proliferation of Tcm and Tem was slightly reduced, both under normal and inflammatory conditions, thus suggesting low sensitivity of memory T cells to contacts with MHC, and, probably, a requirement for additional signals to provide complete stimulation with IL-7. The last suggestion is also supported by data about CD127 and CD132 expression, i.e., in the absence of contact with MHC, the proportion of CD127+CD132+ cells was decreased in both subpopulations of CD4+ memory cells. Upon in vitro cultures, IL-7 contributed to decreased expression of CD127, and increased expression of CD132 on CD4+Tcm and Tem. We have evaluated the CD4+Tcm and Tem populations by affinity of T cell receptor (TCR), using the level of CD5 expression. Т cells with high TCR affinity for self-antigens are known to have higher expression of CD5. In comparison to Tem, the Tcm contained more CD5high cells. In cultures, IL-7 promoted a high level of CD5 expression on Tcm, which was comparable to levels observed in peripheral blood cells. High CD5 expression on Tem was observed after stimulation with IL-7 in the in vitro inflammatory model. In the absence of contact with MHC, the number of CD5high cells decreased among CD4+Tem and Tcm. Thus, CD4+Tcm cells with high affinity for autologous antigens are probably dependent on the presence of homeostatic factors, in particular, IL-7, and contacts with antigen-presenting cells (APCs). Under conditions of inflammation, no changes were revealed in the mechanism of maintaining CD4+Tcm, in contrast to CD4+Tem. Being less dependent on IL-7 under normal conditions, CD4+CD5highTem are accumulated in the presence of IL-7 under in vitro inflammatory conditions.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>центральные Т-клетки памяти</kwd><kwd>эффекторные Т-клетки памяти</kwd><kwd>IL-7</kwd><kwd>рецептор для IL-7</kwd><kwd>CD5</kwd><kwd>провоспалительные цитокины</kwd><kwd>модель воспаления in vitro</kwd></kwd-group><kwd-group xml:lang="en"><kwd>central memory T cells</kwd><kwd>effector memory T cells</kwd><kwd>IL-7</kwd><kwd>IL-7 receptor</kwd><kwd>CD5</kwd><kwd>proinflammatory cytokines</kwd><kwd>inflammation model in vitro</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Российский научный фонд (проект №18-75-00068)</funding-statement></funding-group><funding-group xml:lang="en"><funding-statement>RSF (project №18-75-00068)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Демьянов А.В., Котов А.Ю., Симбирцев А.С. Диагностическая ценность исследования уровней цитокинов в клинической практике // Цитокины и воспаление, 2003. Т. 2, № 3. С. 20-35.</mixed-citation><mixed-citation xml:lang="en">Demyanov A.V., Kotov A.Yu., Simbirtsev A.S. Diagnostic value of cytokine studies in clinical practice. Tsitokiny i vospalenie = Cytokines and Inflammation, 2003, Vol. 2, no. 3, pp. 20-35. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Azzam H.S., Grinberg A., Lui K., Shen H., Shore E.W., Love P.E. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med., 1998, Vol. 188, no. 12, pp. 2301-2311.</mixed-citation><mixed-citation xml:lang="en">Azzam H.S., Grinberg A., Lui K., Shen H., Shore E.W., Love P.E. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med., 1998, Vol. 188, no. 12, pp. 2301-2311.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bani L., David D., Moreau J.L., Cayota A., Nakarai T., Ritz J., Thèzу J. Expression of the IL-2 receptor gamma subunit in resting human CD4 T lymphocytes: mRNA is constitutively transcribed and the protein stored as an intracellular component. Int. Immunol., 1997, Vol. 9, no. 4, pp. 573-580.</mixed-citation><mixed-citation xml:lang="en">Bani L., David D., Moreau J.L., Cayota A., Nakarai T., Ritz J., Thèzу J. Expression of the IL-2 receptor gamma subunit in resting human CD4 T lymphocytes: mRNA is constitutively transcribed and the protein stored as an intracellular component. Int. Immunol., 1997, Vol. 9, no. 4, pp. 573-580.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bikker A., Hack C.E., Lafeber F.P., van Roon J.A. Interleukin-7: a key Mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. Curr. Pharm. Des., 2012, Vol. 18, no. 16, pp. 2347-2356.</mixed-citation><mixed-citation xml:lang="en">Bikker A., Hack C.E., Lafeber F.P., van Roon J.A. Interleukin-7: a key Mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. Curr. Pharm. Des., 2012, Vol. 18, no. 16, pp. 2347-2356.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Caserta S., Zamoyska R. Memories are made of this: synergy of T cell receptor and cytokine signals in CD4(+) central memory cell survival. Trends Immunol., 2007, Vol. 28, no. 6, pp. 245-248.</mixed-citation><mixed-citation xml:lang="en">Caserta S., Zamoyska R. Memories are made of this: synergy of T cell receptor and cytokine signals in CD4(+) central memory cell survival. Trends Immunol., 2007, Vol. 28, no. 6, pp. 245-248.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Churchman S.M., Ponchel F. Interleukin-7 in rheumatoid arthritis. Rheumatology (Oxford), 2008, Vol. 47, no. 6, pp. 753-759.</mixed-citation><mixed-citation xml:lang="en">Churchman S.M., Ponchel F. Interleukin-7 in rheumatoid arthritis. Rheumatology (Oxford), 2008, Vol. 47, no. 6, pp. 753-759.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Friedlein G., El Hage F., Vergnon I., Richon C., Saulnier P., Lecluse Y., Caignard A., Boumsell L., Bismuth G., Chouaib S., Mami-Chouaib F. Human CD5 protects circulating tumor antigenspecific CTL from tumor-mediated activation-induced cell death. J. Immunol., 2007, Vol. 178, no. 11, pp. 6821-6827.</mixed-citation><mixed-citation xml:lang="en">Friedlein G., El Hage F., Vergnon I., Richon C., Saulnier P., Lecluse Y., Caignard A., Boumsell L., Bismuth G., Chouaib S., Mami-Chouaib F. Human CD5 protects circulating tumor antigenspecific CTL from tumor-mediated activation-induced cell death. J. Immunol., 2007, Vol. 178, no. 11, pp. 6821-6827.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fry T.J., Connick E., Fallon J., Lederman M.M., Liewehr D.J., Spritzler J., Steinberg S.M., Wood L.V., Yarchoan R., Zuckerman J., Landay A., Mackall C.L. A potential role for interleukin-7 in T-cell homeostasis. Blood, 2001, Vol. 97, no. 10, pp. 2983-2990.</mixed-citation><mixed-citation xml:lang="en">Fry T.J., Connick E., Fallon J., Lederman M.M., Liewehr D.J., Spritzler J., Steinberg S.M., Wood L.V., Yarchoan R., Zuckerman J., Landay A., Mackall C.L. A potential role for interleukin-7 in T-cell homeostasis. Blood, 2001, Vol. 97, no. 10, pp. 2983-2990.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gattinoni L., Speiser D.E., Lichterfeld M., Bonini C. T memory stem cells in health and disease. Nat. Med., 2017, Vol. 23, no. 1, pp. 18-27.</mixed-citation><mixed-citation xml:lang="en">Gattinoni L., Speiser D.E., Lichterfeld M., Bonini C. T memory stem cells in health and disease. Nat. Med., 2017, Vol. 23, no. 1, pp. 18-27.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Henriques C.M., Rino J., Nibbs R.J., Graham G.J., Barata J.T. IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells. Blood, 2010, Vol. 115, no. 16, pp. 3269-3277.</mixed-citation><mixed-citation xml:lang="en">Henriques C.M., Rino J., Nibbs R.J., Graham G.J., Barata J.T. IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells. Blood, 2010, Vol. 115, no. 16, pp. 3269-3277.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hong C., Luckey M.A., Ligons D.L., Waickman A.T., Park J.Y., Kim G.Y., Keller H.R., Etzensperger R., Tai X., Lazarevic V., Feigenbaum L., Catalfamo M., Walsh S.T.R., Park J.-H. Activated T cells secrete an alternatively spliced form of common gamma-chain that inhibits cytokine signaling and exacerbates inflammation. Immunity, 2014, Vol. 40, no. 6, pp. 910-923.</mixed-citation><mixed-citation xml:lang="en">Hong C., Luckey M.A., Ligons D.L., Waickman A.T., Park J.Y., Kim G.Y., Keller H.R., Etzensperger R., Tai X., Lazarevic V., Feigenbaum L., Catalfamo M., Walsh S.T.R., Park J.-H. Activated T cells secrete an alternatively spliced form of common gamma-chain that inhibits cytokine signaling and exacerbates inflammation. Immunity, 2014, Vol. 40, no. 6, pp. 910-923.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lenz D.C., Kurz S.K., Lemmens E., Schoenberger S.P., Sprent J., Oldstone M.B., Homann D. IL-7 regulates basal homeostatic proliferation of antiviral CD4+ T cell memory. Proc. Natl. Acad. Sci. USA, 2004, Vol. 101, no. 25, pp. 9357-9362.</mixed-citation><mixed-citation xml:lang="en">Lenz D.C., Kurz S.K., Lemmens E., Schoenberger S.P., Sprent J., Oldstone M.B., Homann D. IL-7 regulates basal homeostatic proliferation of antiviral CD4+ T cell memory. Proc. Natl. Acad. Sci. USA, 2004, Vol. 101, no. 25, pp. 9357-9362.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Leung S., Liu X., Fang L., Chen X., Guo T., Zhang J. The cytokine milieu in the interplay of pathogenic Th1/ Th17 cells and regulatory T cells in autoimmune disease. Cell. Mol. Immunol., 2010, Vol. 7, no. 3, pp. 182-189.</mixed-citation><mixed-citation xml:lang="en">Leung S., Liu X., Fang L., Chen X., Guo T., Zhang J. The cytokine milieu in the interplay of pathogenic Th1/ Th17 cells and regulatory T cells in autoimmune disease. Cell. Mol. Immunol., 2010, Vol. 7, no. 3, pp. 182-189.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Maldonado A., Mueller Y.M., Thomas P., Bojczuk P., O’Connors C., Katsikis P.D. Decreased effector memory CD45RA+CD62LCD8+ T cells and increased central memory CD45RA-CD62L+CD8+ T cells in peripheral blood of rheumatoid arthritis patients. Arthritis Res. Ther., 2003, Vol. 5, no. 2, pp. R91-R96.</mixed-citation><mixed-citation xml:lang="en">Maldonado A., Mueller Y.M., Thomas P., Bojczuk P., O’Connors C., Katsikis P.D. Decreased effector memory CD45RA+CD62LCD8+ T cells and increased central memory CD45RA-CD62L+CD8+ T cells in peripheral blood of rheumatoid arthritis patients. Arthritis Res. Ther., 2003, Vol. 5, no. 2, pp. R91-R96.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mazzucchelli R., Durum S.K. Interleukin-7 receptor expression: intelligent design. Nat. Rev. Immunol., 2007, Vol. 7, no. 2, pp. 144-154.</mixed-citation><mixed-citation xml:lang="en">Mazzucchelli R., Durum S.K. Interleukin-7 receptor expression: intelligent design. Nat. Rev. Immunol., 2007, Vol. 7, no. 2, pp. 144-154.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Nakarai T., Robertson M.J., Streuli M., Wu Z., Ciardelli T.L., Smith K.A., Ritz J. Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells. J. Exp. Med., 1994, Vol. 180, no. 1, pp. 241-251.</mixed-citation><mixed-citation xml:lang="en">Nakarai T., Robertson M.J., Streuli M., Wu Z., Ciardelli T.L., Smith K.A., Ritz J. Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells. J. Exp. Med., 1994, Vol. 180, no. 1, pp. 241-251.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ordoñez-Rueda D., Lozano F., Sarukhan A., Raman C., Garcia-Zepeda E.A., Soldevila G. Increased numbers of thymic and peripheral CD4+CD25+Foxp3+ cells in the absence of CD5 signaling. Eur. J. Immunol., 2009, Vol. 39, no. 8, pp. 2233-2247.</mixed-citation><mixed-citation xml:lang="en">Ordoñez-Rueda D., Lozano F., Sarukhan A., Raman C., Garcia-Zepeda E.A., Soldevila G. Increased numbers of thymic and peripheral CD4+CD25+Foxp3+ cells in the absence of CD5 signaling. Eur. J. Immunol., 2009, Vol. 39, no. 8, pp. 2233-2247.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Paukku K., Silvennoinen O. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine Growth Factor Rev., 2004, Vol. 15, no. 6, pp. 435-455.</mixed-citation><mixed-citation xml:lang="en">Paukku K., Silvennoinen O. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine Growth Factor Rev., 2004, Vol. 15, no. 6, pp. 435-455.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Persaud S.P., Parker C.R., Lo W.L., Weber K.S., Allen P.M. Intrinsic CD4+ T cell sensitivity and response to a pathogen are set and sustained by avidity for thymic and peripheral complexes of self peptide and MHC. Nat. Immunol., 2014, Vol. 15, no. 3, pp. 266-274.</mixed-citation><mixed-citation xml:lang="en">Persaud S.P., Parker C.R., Lo W.L., Weber K.S., Allen P.M. Intrinsic CD4+ T cell sensitivity and response to a pathogen are set and sustained by avidity for thymic and peripheral complexes of self peptide and MHC. Nat. Immunol., 2014, Vol. 15, no. 3, pp. 266-274.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Pickens S.R., Chamberlain N.D., Volin M.V. Pope R.M., Talarico N.E., Mandelin A.M. 2nd, Shahrara S. Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. Arthritis Rheum., 2011, Vol. 63, no. 10, pp. 2884-2893.</mixed-citation><mixed-citation xml:lang="en">Pickens S.R., Chamberlain N.D., Volin M.V. Pope R.M., Talarico N.E., Mandelin A.M. 2nd, Shahrara S. Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. Arthritis Rheum., 2011, Vol. 63, no. 10, pp. 2884-2893.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Read K.A., Powell M.D., McDonald P.W., Oestreich K.J. IL-2, IL-7, and IL-15: multistage regulators of CD4(+) T helper cell differentiation. Exp. Hematol., 2016, Vol. 44, no. 9, pp. 799-808.</mixed-citation><mixed-citation xml:lang="en">Read K.A., Powell M.D., McDonald P.W., Oestreich K.J. IL-2, IL-7, and IL-15: multistage regulators of CD4(+) T helper cell differentiation. Exp. Hematol., 2016, Vol. 44, no. 9, pp. 799-808.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sasson S.C., Zaunders J.J., Zanetti G., King E.M., Merlin K.M., Smith D.E., Stanley K.K., Cooper D.A., Kelleher A.D. Increased plasma interleukin-7 level correlates with decreased CD127 and increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J. Infect. Dis., 2006, Vol. 193, no. 4, pp. 505-514.</mixed-citation><mixed-citation xml:lang="en">Sasson S.C., Zaunders J.J., Zanetti G., King E.M., Merlin K.M., Smith D.E., Stanley K.K., Cooper D.A., Kelleher A.D. Increased plasma interleukin-7 level correlates with decreased CD127 and increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J. Infect. Dis., 2006, Vol. 193, no. 4, pp. 505-514.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Seyfarth J., Mütze N., Antony Cruz J., Kummer S., Reinauer C., Mayatepek E., Meissner T., Jacobsen M. CD4+ T-cells with high common γ chain expression and disturbed cytokine production are enriched in children with type-1 diabetes. Front. Immunol., 2019, Vol. 10, 820. doi: 10.3389/fimmu.2019.00820.</mixed-citation><mixed-citation xml:lang="en">Seyfarth J., Mütze N., Antony Cruz J., Kummer S., Reinauer C., Mayatepek E., Meissner T., Jacobsen M. CD4+ T-cells with high common γ chain expression and disturbed cytokine production are enriched in children with type-1 diabetes. Front. Immunol., 2019, Vol. 10, 820. doi: 10.3389/fimmu.2019.00820.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Waickman A.T., Park J.Y., Park J.H. The common gamma-chain cytokine receptor: tricks-and-treats for T cells. Cell. Mol. Life Sci., 2016, Vol. 73, no. 2, pp. 253-269.</mixed-citation><mixed-citation xml:lang="en">Waickman A.T., Park J.Y., Park J.H. The common gamma-chain cytokine receptor: tricks-and-treats for T cells. Cell. Mol. Life Sci., 2016, Vol. 73, no. 2, pp. 253-269.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X.S., Li B.Z., Hu L.F., Wen P.F., Zhang M., Pan H.F., Ye D.Q. Perspectives of the relationship between IL-7 and autoimmune diseases. Clin. Rheumatol., 2013, Vol. 32, no. 12, pp. 1703-1709.</mixed-citation><mixed-citation xml:lang="en">Wang X.S., Li B.Z., Hu L.F., Wen P.F., Zhang M., Pan H.F., Ye D.Q. Perspectives of the relationship between IL-7 and autoimmune diseases. Clin. Rheumatol., 2013, Vol. 32, no. 12, pp. 1703-1709.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou X.Y., Yashiro-Ohtani Y., Toyo-Oka K., Park C.S., Tai X.G., Hamaoka T. and Fujiwara H. CD5 costimulation up-regulates the signaling to extracellular signal-regulated kinase activation in CD4+CD8+ thymocytes and supports their differentiation to the CD4 lineage. J. Immunol., 2000, Vol. 164, no. 3, pp. 1260-1268.</mixed-citation><mixed-citation xml:lang="en">Zhou X.Y., Yashiro-Ohtani Y., Toyo-Oka K., Park C.S., Tai X.G., Hamaoka T. and Fujiwara H. CD5 costimulation up-regulates the signaling to extracellular signal-regulated kinase activation in CD4+CD8+ thymocytes and supports their differentiation to the CD4 lineage. J. Immunol., 2000, Vol. 164, no. 3, pp. 1260-1268.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
